The performance of a real-time DNA amplification assay, BD ProbeTec ET System (BDPT, BD Diagnostic Systems), to detect Chlamydia trachomatis and Neisseria gonorrhoeae on endocervical and oropharyngeal samples was evaluated. After obtaining informed consent, 364 endocervical, 363 urine and 247 oropharyngeal specimens were collected from 307 cases. The overall agreement rate of the BDPT and Amplicor (AMP, Roche) assays for the detection of C. trachomatis and N. gonorrhoeae in endocervical samples was 99.2% (361/364) for C. trachomatis and 99.5% (362/364) for N. gonorrhoeae. Assay of oropharyngeal swabs by the BDPT yielded 21 C. trachomatis positives, and 19 of them were C. trachomatis negative by the DNA probe assay (Gen-Probe PACE). The AMP assay showed that 16/19 (84.2%) of the BDPT +/DNA probe - samples were positive. The BDPT also yielded 21 N. gonorrhoeae positives, 15 of which were negative with the DNA probe. Additional testing showed that all 15 BDPT +/DNA probe - samples were positive by the established nested PCR method. Our data suggest that the performance of the BDPT is comparable to that of AMP for detection of C. trachomatis and N. gonorrhoeae in endocervical swab samples and that it may be a useful method for detecting of C. trachomatis and N. gonorrhoeae in oropharyngeal samples clinically.

Download full-text PDF

Source
http://dx.doi.org/10.11150/kansenshogakuzasshi1970.80.251DOI Listing

Publication Analysis

Top Keywords

gonorrhoeae endocervical
12
trachomatis gonorrhoeae
12
trachomatis
8
chlamydia trachomatis
8
trachomatis neisseria
8
neisseria gonorrhoeae
8
oropharyngeal samples
8
detection trachomatis
8
bdpt yielded
8
negative dna
8

Similar Publications

Objectives: The aim of this study was to determine the prevalence of HPV and cytological alterations in the transgender population and contribute to the development of public policies.

Methods: A descriptive study was conducted in a transgender outpatient clinic in Vitória, Espírito Santo state, between 2018 and 2021. Data were collected through interviews and information from medical records.

View Article and Find Full Text PDF

Multicenter Clinical Performance Evaluation of the NeuMoDx™ CT/NG Assay 2.0.

Sex Transm Dis

December 2024

QIAGEN Ltd, Hathersage Road, Manchester, M13 0BH, UK.

Background: Given the continued increases in rates of both Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection, additional diagnostic assays may be useful in increasing access to testing for these sexually transmitted infections. We evaluated the performance of the NeuMoDx™ CT/NG Assay 2.0 on the NeuMoDx-96 and NeuMoDx-288 Molecular Systems.

View Article and Find Full Text PDF

Neisseria gonorrhoeae induces local secretion of IL-10 at the human cervix to promote colonization.

J Clin Invest

November 2024

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA.

Gonorrhea, caused by the human-restricted pathogen Neisseria gonorrhoeae, is a commonly reported sexually transmitted infection. Since most infections in women are asymptomatic, the true number of infections is likely much higher than reported. How gonococci (GC) colonize women's cervixes without triggering symptoms remains elusive.

View Article and Find Full Text PDF
Article Synopsis
  • Contact-dependent hemolysins are key virulence factors in certain human pathogens, like gonococci, with phospholipase A being a notable outer membrane protein that can lyse human red blood cells over three days.
  • Mutations in the phospholipase A gene significantly impair the bacteria's ability to survive in human immune cells, indicating its critical role in pathogenesis.
  • The inability of phospholipase A mutants to effectively lyse host cells underscores its importance for gonococcal survival and evasion of the host's immune response.
View Article and Find Full Text PDF
Article Synopsis
  • Cervical cancer in Mozambique is influenced by HPV and higher rates are seen in HIV-positive women; this study looks at Chlamydia (CT) and Neisseria gonorrhoeae (NG) prevalence among these groups using the VIA screening method.
  • From 117 women tested, CT was present in 6.8% and NG in 2.6%, but no strong links were found between these STIs and factors like age or HIV status.
  • The findings suggest a notable STI burden among VIA-positive women, advocating for STI screening to be included in cervical cancer prevention efforts.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!